Review



goat anti igf1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems goat anti igf1
    Goat Anti Igf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 107 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/bio_rxiv__2025__11__19__689194-260-72-75?v=R%26D+Systems
    Average 93 stars, based on 107 article reviews
    goat anti igf1 - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems goat anti igf1
    Goat Anti Igf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/bio_rxiv__2025__11__19__689194-260-72-75?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    goat anti igf1 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems mab2913 igf1 goat
    Mab2913 Igf1 Goat, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pm40770097-899-71-69?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    mab2913 igf1 goat - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    OriGene igf1
    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of <t>IGF1</t> and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.
    Igf1, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pmc11698969-288-19-21?v=OriGene
    Average 93 stars, based on 1 article reviews
    igf1 - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc goat anti igf1
    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of <t>IGF1</t> and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.
    Goat Anti Igf1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pm37531435-284-57-61?v=Danaher+Inc
    Average 86 stars, based on 1 article reviews
    goat anti igf1 - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    90
    R&D Systems goat anti-igf1
    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of <t>IGF1</t> and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.
    Goat Anti Igf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pm34471138-340-102-105?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    goat anti-igf1 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    Bio-Rad anti igf1 antibody solution
    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of <t>IGF1</t> and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.
    Anti Igf1 Antibody Solution, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pmc08616707-110-7-16?v=Bio-Rad
    Average 93 stars, based on 1 article reviews
    anti igf1 antibody solution - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher goat anti-igf1
    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of <t>IGF1</t> and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.
    Goat Anti Igf1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/goat+anti+igf1/pm31034883-102-14-29?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    goat anti-igf1 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of IGF1 and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.

    Journal: Nature Communications

    Article Title: A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause

    doi: 10.1038/s41467-024-55440-2

    Figure Lengend Snippet: A Differences in cellular composition between the proliferative- ( n = 4) and secretory phases ( n = 3) of the menstrual cycle based on scRNA-seq data (two-sided t -test). Data are represented using a boxplot showing the median and first and third quantile. N describes the number of patients/ samples for each respective menstrual cycle phase. SE1 p-value < 0.0018, SE2 p -value < 0.0035. B Representative OVGP1 immunohistochemistry in the fallopian tube of patients in the proliferative phase ( n = 2) and in the secretory phase ( n = 2). C Scatter plot comparing gene expression levels of pre-menopausal SE1 (secretory phase) and SE2 cells (proliferative phase) using pseudo-bulk RNA analysis. D Volcano plot derived from pseudo bulk analysis. The volcano plot shows the differential gene expression analysis of genes expressed in SE cells (SE 1/2/3-pre) based on the proliferative and secretory phases. E Number of differentially expressed genes between the proliferative- and secretory phases of the menstrual cycle by cell clusters based on scRNA-seq data. F Dot plot showing normalized scRNA-seq derived gene expression levels of selected genes that differ in the proliferative and secretory phase in ST subtypes. G Representative immunofluorescence staining of IGF1 and IGF2 in primary human stromal and epithelial fallopian cell co-culture of one patient ( n = 3). The co-culture was stimulated for 8 h with estrogen (E4) or progesterone (P4). IGF1 protein in green, IGF2 protein in red and nuclei/ DAPI in blue. White dotted lines mark epithelial cells while white stars mark stromal cells. H Ligand-receptor interactions, detected by CellPhoneDB, between SE and ST subtypes (left) and between SE cells (right) separated by the menstrual phase using scRNA-seq data. I RNA velocity analysis of SE1- and SE2-pre cells. Arrows indicate the location of the estimated future cell state. Long vectors mark rapid transition events (i.e., large changes in gene expression), while short arrows indicate homeostasis. J Median latent time for pre-menopausal SE cells during the proliferative- and secretory phase of the menstrual cycle, highlighting temporal positions for SE1- and SE2-pre.

    Article Snippet: Slides were stained overnight at 4 °C in goat serum (Thermo Fisher Scientific, Cat#16210064) using the following primary antibodies: IGF1 (1:200, OriGene Technologies, TA805748S) and IGF2 (1:200, ThermoFisher scientific, MA532485), followed by fluorescently labeled secondary antibodies (1:200, Alexa Fluor 488 and 568, Invitrogen) and Hoechst 33258 (1:200, Molecular probes, H-3569) for 1 h. We imaged slides on a Nikon Eclipse Ti2 microscope and processed images with NIS-Elements (Nikon).

    Techniques: Immunohistochemistry, Gene Expression, Derivative Assay, Immunofluorescence, Staining, Co-Culture Assay